Having engineered NDV vectors that mediate localized CD47 blockade, we sought to examine whether these rNDVs mediate a survival benefit in the B16-F10 melanoma model, as our in vitro results indicated B16-F10 melanoma supported the most transgene production and had the highest increase in CD47 expression (Figure 1A). Here, CD47 is linked to melanoma.